A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (12) , 2355-2361
- https://doi.org/10.1016/j.jacc.2004.09.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cardioversion of atrial fibrillation with ibutilide: When is it most effective?Clinical Cardiology, 2002
- Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillationThe American Journal of Cardiology, 1995
- Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled studyAmerican Heart Journal, 1995
- Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onsetThe American Journal of Cardiology, 1989
- Efficacy of intravenous propafenone for the acute management of atrial fibrillationThe American Journal of Cardiology, 1989
- Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythmThe American Journal of Cardiology, 1989
- Intravenous flecainide acetate for supraventricular tachycardiasThe American Journal of Cardiology, 1988
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986
- Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular responseInternational Journal of Cardiology, 1985
- Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusionAmerican Heart Journal, 1983